Rafael Amado - 03 Apr 2023 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
President, Head of Global Oncology Research and Development
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2023, 16:05:39 UTC
Previous filing
03 Jan 2023
Next filing
14 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Award $0 +113,217 $0.000000 113,217 03 Apr 2023 American Depositary Shares 113,217 $33.95 Direct F1, F2, F3
transaction ZLAB Restricted Share Units Award $0 +21,564 $0.000000 21,564 03 Apr 2023 American Depositary Shares 21,564 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.
F2 The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.
F3 Each ADS represents ten Ordinary Shares of the issuer.
F4 Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
F5 The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.

Remarks:

President, Head of Global Oncology Research and Development